Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 10 records, 1 pages
Search For: Renin-Inhibitors
Global Renin-Inhibitors Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
13 Jan 2025
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Renin-Inhibitors market size was valued at US$ 107 million in 2024 and is forecast to a readjusted size of USD 167 million by 2031 with a CAGR of 6.6% during review period.
USD3480.00
Add To Cart
Global Renin-Inhibitors Supply, Demand and Key Producers, 2024-2030
09 Feb 2024
Pharma & Healthcare
The global Renin-Inhibitors market size is expected to reach $ 145.6 million by 2030, rising at a market growth of 6.5% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Renin-Inhibitors Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Renin-Inhibitors market size was valued at USD 94 million in 2023 and is forecast to a readjusted size of USD 145.6 million by 2030 with a CAGR of 6.5% during review period.
USD3480.00
Add To Cart
Global Direct Renin Inhibitors Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Direct Renin Inhibitors market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Direct Renin Inhibitors (DRIs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
Direct Renin Inhibitors (DRIs)
According to our (Global Info Research) latest study, the global Direct Renin Inhibitors (DRIs) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Renin-Inhibitors Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
18 Mar 2023
Pharma & Healthcare
Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.
USD3480.00
Add To Cart
Global Direct Renin Inhibitors Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
26 Aug 2023
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Direct Renin Inhibitors market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Direct Renin Inhibitors Supply, Demand and Key Producers, 2023-2029
26 Aug 2023
Pharma & Healthcare
The global Direct Renin Inhibitors market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Direct Renin Inhibitors (DRIs) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
26 Aug 2023
Pharma & Healthcare
Direct Renin Inhibitors (DRIs)
According to our (Global Info Research) latest study, the global Direct Renin Inhibitors (DRIs) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Direct Renin Inhibitors (DRIs) Supply, Demand and Key Producers, 2023-2029
26 Aug 2023
Pharma & Healthcare
Direct Renin Inhibitors (DRIs)
The global Direct Renin Inhibitors (DRIs) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Renin-Inhibitors
Total: 10 records, 1 pages
According to our (Global Info Research) latest study, the global Renin-Inhibitors market size was valued at US$ 107 million in 2024 and is forecast to a readjusted size of USD 167 million by 2031 with a CAGR of 6.6% during review period.
USD3480.00
Add To Cart
The global Renin-Inhibitors market size is expected to reach $ 145.6 million by 2030, rising at a market growth of 6.5% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Renin-Inhibitors market size was valued at USD 94 million in 2023 and is forecast to a readjusted size of USD 145.6 million by 2030 with a CAGR of 6.5% during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Direct Renin Inhibitors market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Direct Renin Inhibitors (DRIs) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Direct Renin Inhibitors market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
USD3480.00
Add To Cart
The global Direct Renin Inhibitors market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Direct Renin Inhibitors (DRIs) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
USD3480.00
Add To Cart
The global Direct Renin Inhibitors (DRIs) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>